Plenary member companies develop new medicinal products for human use for Pulmonary or Nasal route of delivery intended to be used in the European Market. This does not explicitly mean that a plenary member company needs to sell, or be the MAA or IMPD holder of one of these products. Exceptions can be made based on significant contributions to the field.
New member company applications are reviewed by existing members and must follow the “Votes / Agreements / Decisions” principal of:
Any motion proposed requires a minimum of 50% plenary membership support, one vote per company
If you would like to apply to become a member of EPAG please fill out the form below.